✦ LIBER ✦

Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study

✍ Scribed by Al-Ali, Haifa K.; Jaekel, Nadja; Junghanss, Christian; Maschmeyer, Georg; Krahl, Rainer; Cross, Michael; Hoppe, Gisa; Niederwieser, Dietger

Book ID: 111650401
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 309 KB
Volume: 53
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2011.606382

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II multicenter study to assess t

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

✍ H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB

A phase I/II study of oral etoposide and

A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy

✍ Michael Fiegl; Thomas Büchner; Wolfgang Hiddemann; Jan Braess 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 84 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

Continuous infusion of intermediate-dose

Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

✍ Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

Multicenter randomized phase II trial of

Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia

✍ Archimbaud, E; Jehn, U; Thomas, X; De Cataldo, F; Fillet, G; Belhabri, A; Peaud, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

A Novel High Dose Chemotherapy Strategy

A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients

✍ G. Visani; L. Malerba; P.M. Stefani; S. Capria; P. Galieni; F. Gaudio; G. Specch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB